1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Taraxerol | 蒲公英萜醇 | 127-22-0 |
| Deoxyelephantopin | 去氧地胆草素 | 29307-03-7 |
| Licochalcone D | 甘草查尔酮 D | 144506-15-0 |
| Eurycomalactone | 东革内酯 | 23062-24-0 |
| Kamebakaurin | KAMEBAKAURINE;KAMEBAKAURIN | 73981-34-7 |
| Asatone | 细辛酮 | 38451-63-7 |
| Armepavine | 亚美罂粟碱 | 524-20-9 |
| Ergolide | 麦角内酯 | 54999-07-4 |
| Toralactone | 决明内酯 | 41743-74-2 |
| SN50 | 213546-53-3 | 213546-53-3 |
| TAT-14 | TAT 14 | 1362661-34-4 |
| 4-O-Methyl honokiol | 4'-甲氧基-3',5-二-2-丙烯基-(1,1'-联苯)-2-醇 | 68592-15-4 |
| Methyl 3,4-dihydroxybenzoate | 3,4-二羟基苯甲酸甲酯 | 2150-43-8 |
| AZD0156 | AZD0156 | 1821428-35-6 |
| BAY1125976 | CS-2913 | 1402608-02-9 |
| PQR620 | PQR620游离态 | 1927857-56-4 |
| PI4KIIIbeta-IN-10 | 1881233-39-1 | 1881233-39-1 |
| CP21R7 | GSK-3Β抑制剂(CP21R7) | 125314-13-8 |
| CZ415 | CZ415 | 1429639-50-8 |
| MELK-8a hydrochloride | MELK8A HYDROCHLORIDE | 2096992-20-8 |
| PF-04979064 | CS-2664 | 1220699-06-8 |
| WYE-132 | N-[4-[1-(1,4-二氧杂螺[4.5]癸烷-8-基)-4-(8-氧杂-3-氮杂双环[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]-N'-甲基脲 | 1144068-46-1 |
| NSC781406 | 1676893-24-5 | 1676893-24-5 |
| CGS 15943 | CGS 15943 | 104615-18-1 |
| IPI549 | IPI-549 | 1693758-51-8 |
| AS-605240 | 5-(6-喹喔啉亚甲基)-2,4-噻唑啉二酮 | 648450-29-7 |
| IC-87114 | 2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 | 371242-69-2 |
| TG100-115 | 3,3'-(2,4-二氨基-6,7-蝶啶二基)二苯酚 | 677297-51-7 |
| TGX-221 | (+/-)-7-甲基-2-(吗啉-4-基)-9-(1-苯基氨基乙基)吡啶并[1,2-A]嘧啶-4-酮 | 663619-89-4 |
| PI-103 | PI-103 | 371935-74-9 |
| PI-103 Hydrochloride | PI-103 (Hydrochloride) | 371935-79-4 |
| GDC-0326 | GDC0326 | 1282514-88-8 |
| GDC-0077 | GDC-0077 | 2060571-02-8 |
| Recilisib | RECILISIB 钠盐 | 334969-03-8 |
| CHIR-99021 monohydrochloride | CHIR-99021盐酸盐 | 1797989-42-4 |
| CHIR-99021 trihydrochloride | 1782235-14-6 | 1782235-14-6 |
| PI-273 | PI-273 | 925069-34-7 |
| KDU731 | KDU731 | 1610610-48-4 |
| K00546 | Cdk1/2 Inhibitor III | 443798-47-8 |
| OSI-027 | 反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 | 936890-98-1 |
| A-443654 | (ALPHAS)-ALPHA-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧基]甲基]-(S)-1H-吲哚-3-乙胺 | 552325-16-3 |
| OSU-03012 | 2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 | 742112-33-0 |
| TWS119 | TWS119 | 601514-19-6 |
| PKI-402 | PKI-402 | 1173204-81-3 |
| PF-AKT400 | (S)-N-[[3-氨基-1-(5-乙基-7H-吡咯并[2,3-D]嘧啶-4-基)吡咯烷-3-基]甲基]-2,4-二氟苯甲酰胺 | 1004990-28-6 |
| PQR530 | PQR530 | 1927857-61-1 |
| A 1070722 | 1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea | 1384424-80-9 |
| GNE-493 | GNE-493 | 1033735-94-2 |
| T-00127_HEV1 | 化合物 T16967 | 900874-91-1 |
| PI-828 | 8-(4-氨基苯基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 | 942289-87-4 |
| Parsaclisib | 化合物PARSACLISIB | 1426698-88-5 |
| BX-912 | BX-912 | 702674-56-4 |
| (Z)-Guggulsterone | 孕二烯二酮 | 39025-23-5 |
| TDZD-8 | 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE | 327036-89-5 |
| Metformin D6 hydrochloride | 二甲双胍盐酸 | 1185166-01-1 |
| GNE-477 | GNE 477 | 1032754-81-6 |
| Pilaralisib analogue | XL147 | 956958-53-5 |
| BIP-135 | 3-(5-BroMo-1-Methyl-1H-indol-3-yl)-4-(benzofuran-3-yl)pyrrole-2,5-dione | 941575-71-9 |
| MK8722 | MK-8722 | 1394371-71-1 |
| PI3Kδ-IN-2 | YY-20394 | 1702816-75-8 |
| AKT Kinase Inhibitor | AKT 激酶抑制剂 | 842148-40-7 |
| Omipalisib | GSK2126458 | 1086062-66-9 |
| PIK-294 | PIK-294 | 900185-02-6 |
| AZD 6482 | 2-[[(1R)-1-[7-甲基-2-(4-吗啉)-4-氧代-4H-吡啶并[1,2-A]嘧啶-9-基]乙基]氨基]苯甲酸 | 1173900-33-8 |
| RapaLink-1 | RapaLink-1 | 1887095-82-0 |
| EHT 5372 | CS-2911 | 1425945-60-3 |
| PI3K/mTOR Inhibitor-2 | PI3K/mTOR 抑制剂-2 | 1848242-58-9 |
| IPI-3063 | 化合物IPI-3063 | 1425043-73-7 |
| 5-Iodo-indirubin-3'-monoxime | 5-IODO-INDIRUBIN-3'-MONOXIME | 331467-03-9 |
| Chitosan oligosaccharide | 壳聚糖低聚乳酸酯 | 148411-57-8 |
| UCT943 | UCT943 | 1450666-80-4 |
| AZD3458 | AZD-3458 | 2132961-46-5 |
| UCB9608 | (S)-4-(6-氨基-1-甲基-1H-吡唑并[3,4-D]嘧啶-4-基)-N-(4-甲氧基-2-甲基苯基)-3-甲基哌嗪-1-甲酰胺 | 1616413-96-7 |
| IITZ-01 | IITZ-01 | 1807988-47-1 |
| mTOR inhibitor-1 | 152-53-4 | 468747-17-3 |
| 9-ING-41 | 9-ING-41 | 1034895-42-5 |
| HDACs/mTOR Inhibitor 1 | HDACS/MTOR INHIBITOR 1 | 2271413-06-8 |
| P110δ-IN-1 | ME401 | 1595129-71-7 |
| EB-3D | EB-3D | 1839150-63-8 |
| BRD0705 | BRD0705 | 2056261-41-5 |
| Hematein | 氧化苏木精 | 475-25-2 |
| WYE-354 | 4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 | 1062169-56-5 |
| GSK1059615 | (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 | 958852-01-2 |
| Rigosertib sodium | 瑞格色替钠 | 592542-60-4 |
| Rigosertib | 瑞格色替 | 592542-59-1 |
| KU-60019 | KU 60019 | 925701-46-8 |
| PHT-427 | 4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 | 1191951-57-1 |
| JR-AB2-011 | JR-AB2-011 | 2411853-34-2 |
| STL127705 | 化合物STL127705 | 1326852-06-5 |
| Umbralisib hydrochloride | 1532533-78-0 | 1532533-78-0 |
| Serabelisib | [6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮 | 1268454-23-4 |
| Borussertib | Borussertib | 1800070-77-2 |
| IM-12 | IM-12 | 1129669-05-1 |
| AZD8186 | 8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | 1627494-13-6 |
| ON 146040 | 1404231-34-0 | 1404231-34-0 |
| ETP-46321 | CS-2500 | 1252594-99-2 |
| JNJ-47117096 hydrochloride | 1610536-69-0 | 1610536-69-0 |
| (R)-BRD3731 | 2056262-08-7 | |
| BRD3731 | 5H-Pyrazolo[3,4-b]quinolin-5-one, 3-(2,2-dimethylpropyl)-1,2,4,6,7,8-hexahydro-4,7,7-trimethyl-4-phenyl-, (4S)- | 2056262-07-6 |
| Vps34-IN-2 | (S)-1-(3-methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one | 1523404-29-6 |
联系方式
